相关实验视频
Updated: Jun 23, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
289
皮症中的SIRT1信号通路:新的机制和潜在的治疗点
Luning Yang1, Di Liu2, Shide Jiang3
1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China.
概括
赛尔图因1 (SIRT1) 通过调节关键的细胞通路,在衰老肌肉损失 (肉类衰老) 中发挥关键作用. 向SIRT1提供了潜在的治疗策略,用于预防和治疗肉症.
科学领域:
- 老年学和肌肉生理学
背景情况:
- 萨科佩尼亚是一种与年龄相关的肌肉疾病,显著降低了老年人的生活质量.
- Sirtuin 1 (SIRT1),一种依赖NAD+的脱乙酶,与衰老和各种疾病有关.
研究的目的:
- 审查SIRT1在肉病原病的机制.
- 总结了针对肉症SIRT1的治疗干预措施.
主要方法:
- 对SIRT1在骨肌肉衰老中的作用的文献综述.
- 分析SIRT1介导的蛋白质稳态,亡,线粒体功能,胰岛素抵抗和自的途径.
主要成果:
- SIRT1调节关键通路,包括SIRT1/FoxO,AMPK/SIRT1/NF-κB,SIRT1/p53,AMPK/SIRT1/PGC-1α,以及LKB1/SIRT1/AMPK.这些通路是SIRT1和FoxO之间的关键通路.
- 这些途径对于衰老期间的骨肌肉健康至关重要.
结论:
- SIRT1是肉症发育和进展的中心调节者.
- 干预措施,如SIRT1激活剂,炼和卡路里限制,显示了对萨尔科佩尼亚管理的希望.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K

